Bronnen:
- Palma DA, Olson R, Harrow S3, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019 Apr 10. pii: S0140-6736(18)32487-5. [Epub ahead of print]